Cannabidiol (CBD) types and formulations
Pro Research Analysisby 
Searched over 200M research papers
Types of Cannabidiol (CBD) Formulations
Cannabidiol (CBD) is available in a variety of formulations, each designed to address its poor water solubility, low oral bioavailability, and chemical instability. The most common types include oils, nanoemulsions, lipid-based carriers, self-emulsifying drug delivery systems (SEDDS), and topical preparations. These formulations are developed to improve CBD’s absorption, stability, and therapeutic effectiveness 12347910.
CBD Oils and Hemp Extracts
CBD oils, often derived from hemp, are among the most popular formulations. They are typically mixed with carrier oils such as medium-chain triglycerides (MCT), canola oil, or hemp seed oil. These oils help dissolve CBD and improve its absorption when taken orally. However, the quality and labeling of these products can vary significantly, and there is little regulation to ensure consistency 15.
Nanoemulsions and Colloidal Lipid Carriers
Nanoemulsions are advanced formulations where CBD is dispersed in tiny droplets within a carrier oil. This approach increases the surface area for absorption and enhances bioaccessibility compared to bulk oil forms. Studies show that nanoemulsions using long-chain triglycerides (LCT) as the carrier oil provide better bioaccessibility than those using MCT . Colloidal lipid carriers, such as emulsions made with rapeseed oil, soybean oil, or trimyristin, can achieve high CBD loads and improve stability, although the type of lipid matrix affects the maximum load and stability .
Lipid-Based and Self-Emulsifying Drug Delivery Systems (SEDDS)
Lipid-based formulations, including SEDDS, are designed to improve the oral bioavailability of CBD. These systems use oils and surfactants to form fine emulsions in the digestive tract, enhancing CBD absorption. Clinical studies have shown that SEDDS formulations can result in significantly higher blood levels of CBD and faster absorption compared to traditional oil-based formulations 27. Lipid formulations also reduce the variability in absorption that can be influenced by gut bacteria and bile acids .
Solid-State and Improved Crystal Formulations
Solid-state formulations and improved crystal forms of CBD are being explored to address issues of chemical instability and variable pharmacokinetics. These approaches are mostly in early development but aim to provide more consistent dosing and better shelf stability .
Topical and Transdermal Formulations
Topical CBD formulations are designed for direct application to the skin, targeting localized conditions such as pain or inflammation. The stability and bioactivity of CBD in these formulations depend on the medium used; for example, CBD in organic solvents shows better antimicrobial activity against certain bacteria and fungi than in aqueous solutions . Transdermal systems are also being developed to bypass the digestive system, offering improved bioavailability and targeted delivery .
Key Challenges in CBD Formulation
Chemical Instability and Degradation
CBD is chemically unstable, especially in acidic environments and when exposed to light. This instability can lead to degradation and reduced effectiveness, making formulation and storage conditions critical 13.
Low Oral Bioavailability
CBD’s poor water solubility and extensive first-pass metabolism in the liver result in low and variable oral bioavailability. Lipid-based formulations and taking CBD with food, especially high-fat meals, can significantly enhance absorption and reduce variability 2378.
Regulatory and Quality Concerns
There is a lack of standardization and regulation in the CBD market, leading to inconsistent product quality and labeling. This makes it important for consumers and clinicians to seek out reputable products and be aware of potential discrepancies in CBD content 510.
Conclusion
CBD is available in a range of formulations, including oils, nanoemulsions, lipid-based carriers, SEDDS, and topical preparations. Each type aims to address the challenges of poor solubility, low bioavailability, and chemical instability. Lipid-based and nanoemulsion formulations show the most promise for improving oral absorption, while topical and transdermal systems offer alternatives for targeted delivery. Despite these advances, challenges remain in ensuring product stability, consistent absorption, and regulatory oversight. Continued research and development are needed to optimize CBD formulations for both medical and consumer use 12345678+2 MORE.
Sources and full results
Most relevant research papers on this topic